Page last updated: 2024-08-21

xanthinol niacinate and Experimental Neoplasms

xanthinol niacinate has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crokart, N; Danhier, P; Gallez, B; Grégoire, V; Jordan, BF; Segers, J1

Other Studies

1 other study(ies) available for xanthinol niacinate and Experimental Neoplasms

ArticleYear
Use of Xanthinol Nicotinate as a co-treatment for radio- and chemo-therapy in experimental tumors.
    International journal of cancer, 2010, Jan-15, Volume: 126, Issue:2

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Hemodynamics; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Radiation-Sensitizing Agents; Time Factors; Treatment Outcome; Tumor Burden; Vasodilator Agents; X-Ray Therapy; Xanthinol Niacinate

2010